Benitec Biopharma Inc. (BNTC)
NASDAQ·Healthcare·Biotechnology
$9.83
-10.27%
Mkt Cap $298.17M
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$20.50
Range $16.00 – $25.00
Implied Upside
+108.7%
Consensus $20.50 vs current $9.83
NASDAQ·Healthcare·Biotechnology
$9.83
-10.27%
Mkt Cap $298.17M
No recent rating data.
Price Target (10 analysts)
$20.50
Range $16.00 – $25.00
+108.7%
Consensus $20.50 vs current $9.83